Thomas D. Abert is listed as an executive officer and director on 6 SEC Form D filings by 1 issuer between Jan 2012 and May 2015: ZS Genetics Inc (Wakefield, MA — biotechnology — 2012–2015; $1.72M reported sold to 22 investors).
What this means One deal on file with the SEC. A Form D is the notice a company files after it starts selling a private investment — it is a notice, not an approval.
Listed alongside Frank E. Ferguson (6 shared filings), Jane Hager (6 shared filings), William R Glover (6 shared filings), Thomas A. Shields (3 shared filings), Bill W Ward (2 shared filings) and 1 others.
What this means These are the other officers, directors or promoters the companies named on the same forms — the team around Thomas. Each name links to their own page.
Public records searched: federal courts (CourtListener / RECAP), SEC enforcement releases, state securities regulators (AZ, CA, DE, TX, WA) — none found.
What this means Nothing turned up where we looked (3 sources). That does not prove there is nothing — it means none was found in those sources on that date.
We compared 6 public filings for Thomas D. Abert and found 9 differences, 1 worth asking the sponsor about: Form D filed 613 days after the first sale; and more below.
What this means These are differences between the sponsor's own SEC filings — both values, dates and sources are listed in Key records, section 4. Most have ordinary explanations; ask the sponsor.